OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, will announce its fourth quarter and full year 2015 results on Friday, 26 February 2016.
A presentation by Nordic Nanovector’s senior management team will take place at 8:30 am CET at:
Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo
